Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke.

Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke. Cerebrovasc Dis. 2013; 35(3):220-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.